175 related articles for article (PubMed ID: 17302398)
1. Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.
Ivanov AA; Ko H; Cosyn L; Maddileti S; Besada P; Fricks I; Costanzi S; Harden TK; Calenbergh SV; Jacobson KA
J Med Chem; 2007 Mar; 50(6):1166-76. PubMed ID: 17302398
[TBL] [Abstract][Full Text] [Related]
2. Structure activity and molecular modeling analyses of ribose- and base-modified uridine 5'-triphosphate analogues at the human P2Y2 and P2Y4 receptors.
Jacobson KA; Costanzi S; Ivanov AA; Tchilibon S; Besada P; Gao ZG; Maddileti S; Harden TK
Biochem Pharmacol; 2006 Feb; 71(4):540-9. PubMed ID: 16359641
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.
El-Tayeb A; Qi A; Müller CE
J Med Chem; 2006 Nov; 49(24):7076-87. PubMed ID: 17125260
[TBL] [Abstract][Full Text] [Related]
4. Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
Kim HS; Ravi RG; Marquez VE; Maddileti S; Wihlborg AK; Erlinge D; Malmsjö M; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 Jan; 45(1):208-18. PubMed ID: 11754592
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of agonist-dependent and -independent desensitization of a recombinant P2Y2 nucleotide receptor.
Otero M; Garrad RC; Velázquez B; Hernández-Pérez MG; Camden JM; Erb L; Clarke LL; Turner JT; Weisman GA; González FA
Mol Cell Biochem; 2000 Feb; 205(1-2):115-23. PubMed ID: 10821429
[TBL] [Abstract][Full Text] [Related]
6. Differential agonist-induced desensitization of P2Y2 nucleotide receptors by ATP and UTP.
Velázquez B; Garrad RC; Weisman GA; González FA
Mol Cell Biochem; 2000 Mar; 206(1-2):75-89. PubMed ID: 10839197
[TBL] [Abstract][Full Text] [Related]
7. Ligand binding and activation of UTP-activated G protein-coupled P2Y
Attah IY; Neumann A; Al-Hroub H; Rafehi M; Baqi Y; Namasivayam V; Müller CE
Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129501. PubMed ID: 31812541
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of agonist-induced desensitization and sequestration of the P2Y2 nucleotide receptor. Consequences of truncation of the C terminus.
Garrad RC; Otero MA; Erb L; Theiss PM; Clarke LL; Gonzalez FA; Turner JT; Weisman GA
J Biol Chem; 1998 Nov; 273(45):29437-44. PubMed ID: 9792648
[TBL] [Abstract][Full Text] [Related]
9. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor.
Nicholas RA; Watt WC; Lazarowski ER; Li Q; Harden K
Mol Pharmacol; 1996 Aug; 50(2):224-9. PubMed ID: 8700127
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and P2Y receptor activity of nucleoside 5'-phosphonate derivatives.
Cosyn L; Van Calenbergh S; Joshi BV; Ko H; Carter RL; Kendall Harden T; Jacobson KA
Bioorg Med Chem Lett; 2009 Jun; 19(11):3002-5. PubMed ID: 19419868
[TBL] [Abstract][Full Text] [Related]
11. Desensitization of P2Y2 receptor-activated transepithelial anion secretion.
Clarke LL; Harline MC; Otero MA; Glover GG; Garrad RC; Krugh B; Walker NM; González FA; Turner JT; Weisman GA
Am J Physiol; 1999 Apr; 276(4):C777-87. PubMed ID: 10199807
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors.
Nicholas RA; Lazarowski ER; Watt WC; Li Q; Boyer J; Harden TK
J Auton Pharmacol; 1996 Dec; 16(6):319-23. PubMed ID: 9131407
[TBL] [Abstract][Full Text] [Related]
13. 4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptors.
Jayasekara PS; Barrett MO; Ball CB; Brown KA; Hammes E; Balasubramanian R; Harden TK; Jacobson KA
J Med Chem; 2014 May; 57(9):3874-83. PubMed ID: 24712832
[TBL] [Abstract][Full Text] [Related]
14. Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors.
Burrell HE; Bowler WB; Gallagher JA; Sharpe GR
J Invest Dermatol; 2003 Mar; 120(3):440-7. PubMed ID: 12603858
[TBL] [Abstract][Full Text] [Related]
15. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
Yu Y; Zhang C
Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
[TBL] [Abstract][Full Text] [Related]
16. Apical P2Y4 purinergic receptor controls K+ secretion by vestibular dark cell epithelium.
Marcus DC; Scofield MA
Am J Physiol Cell Physiol; 2001 Jul; 281(1):C282-9. PubMed ID: 11401851
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-dependent relaxation evoked by ATP and UTP in the aorta of P2Y2-deficient mice.
Guns PJ; Van Assche T; Fransen P; Robaye B; Boeynaems JM; Bult H
Br J Pharmacol; 2006 Mar; 147(5):569-74. PubMed ID: 16415908
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonists.
Ko H; Carter RL; Cosyn L; Petrelli R; de Castro S; Besada P; Zhou Y; Cappellacci L; Franchetti P; Grifantini M; Van Calenbergh S; Harden TK; Jacobson KA
Bioorg Med Chem; 2008 Jun; 16(12):6319-32. PubMed ID: 18514530
[TBL] [Abstract][Full Text] [Related]
19. The synthesis of cyclonucleotides with fixed glycosidic bond linkages as putative agonists for P2-purinergic receptors.
Tusa G; Reed JK
Nucleosides Nucleotides Nucleic Acids; 2000 Apr; 19(4):805-13. PubMed ID: 10960037
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced phosphorylation and desensitization of the P2Y2 nucleotide receptor.
Flores RV; Hernández-Pérez MG; Aquino E; Garrad RC; Weisman GA; Gonzalez FA
Mol Cell Biochem; 2005 Dec; 280(1-2):35-45. PubMed ID: 16311903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
